Cell Surface Bio Launches VeRSa-Select™ for Custom Antibodies
Providing custom antibody services that ensure optimal performance for any research target.
Cell Surface Bio (CSB) has proudly announced the introduction of VeRSa-Select™, a groundbreaking custom antibody service that promises researchers unparalleled access to top-tier antibody reagents. Designed specifically for challenging proteins including GPCRs and ion channels, VeRSa-Select™ enhances the capacity for target validation in the ever-evolving realm of biomedical research.
This innovative service offers researchers the capability to generate high-affinity antibodies tailored for virtually any target across various mammalian species. Such diversity includes, but is not limited to, humans, mice, and other non-human primates. The antibodies produced under this service stand out due to their specificity, a critical factor when validating complex therapeutic targets in diverse disease models.
Leveraging Advanced Technology for High-Quality Antibodies
CSB utilizes the state-of-the-art antibody discovery platform of its parent company to create its antibodies. This includes advanced methodologies that enhance the specificity and effectiveness of each reagent. In a world where the proper validation of drug targets is essential for drug discovery, the ability to utilize highly specific antibodies is invaluable. As such, scientists can embark on full-scale drug development with confidence, knowing they are equipped with top-quality reagents that support their research efforts.
Customization and Performance in Antibody Production
With VeRSa-Select™, CSB introduces customizable workflows, aimed at ensuring that each antibody performs reliably across various applications. Whether it involves flow cytometry, immunofluorescence, or immunohistochemistry, researchers can tailor their antibodies to meet the specific requirements of their studies.
- Validation in multiple critical applications to ensure efficacy.
- Comprehensive testing for specificity against an extensive database of over 6,000 native proteins.
- Utilization of recombinant cloning techniques for consistent, reproducible results free of animal-derived reagents.
Ross Chambers, PhD, the VP of Antibody Discovery at Cell Surface Bio, expressed enthusiasm about this service, stating, "Therapeutic antibodies have transformed medicine, and with VeRSa-Select™, we bring that innovation to research antibodies. By incorporating advanced technologies such as virus-like particles and mRNA interactions, we provide reagents that are both specific and effective for difficult targets. This is a significant step forward for researchers looking to validate new drug targets that lack available resources."
VeRSaMAb® Reagents for Challenging Research
In addition to the custom antibody services, CSB continues to expand its portfolio of VeRSaMAb® reagents. These validated, recombinant, and specific monoclonal antibodies are particularly geared toward challenges associated with studying cell surface proteins.
About Cell Surface Bio
Cell Surface Bio is dedicated to delivering high-quality antibody solutions to researchers across various fields. The company’s mission revolves around the understanding that time is a critical element in the lab. With over 20 years of expertise in antibody characterization, CSB’s VeRSaMAb® antibodies provide reliability researchers can depend on. These antibodies are purposefully designed to assist in yielding credible results consistently.
To keep up with the latest from CSB, researchers are encouraged to engage with the company on social media platforms, particularly on LinkedIn, where they can stay informed about the latest advancements and offerings.
Frequently Asked Questions
What is VeRSa-Select™?
VeRSa-Select™ is a custom antibody service by Cell Surface Bio aimed at providing high-quality antibodies for diverse research applications.
What types of proteins can VeRSa-Select™ antibodies target?
These antibodies are designed to target a range of proteins, including complex and structurally challenging targets like GPCRs and ion channels.
How does CSB ensure the quality of its antibodies?
CSB follows rigorous testing procedures, validating antibody specificity against more than 6,000 native proteins to ensure reliability in research applications.
What makes VeRSaMAb® antibodies different?
VeRSaMAb® antibodies are validated, recombinant, and specific, ensuring they meet high standards for research studies involving challenging cell surface proteins.
How can researchers get in touch with CSB?
Researchers can reach out to Cell Surface Bio through their official website for inquiries or more information about their services.
